Manuscripts

Abstracts

June 2, 2023

The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations

ASCO Annual Meeting 2023

Gray J E et al

June 2, 2023

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

ASCO Annual Meeting 2023

McKelvey B A et al

June 2, 2023

Electronic health record (EHR) and genomics-based machine learning (ML) to predict therapeutic effectiveness among patients with hormone-receptor positive (HR)+/HER2-advanced breast cancer (aBC)

ASCO Annual Meeting 2023

Hathi D et al

June 2, 2023

Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer

ASCO Annual Meeting 2023

Naidoo J et al